Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.

Expression in Escherichia coli of his-tagged human mevalonate diphosphate decarboxylase (hMDD) has expedited enzyme isolation, characterization, functional investigation of the mevalonate diphosphate binding site, and crystal structure determination (2.4A resolution). hMDD exhibits V(max)=6.1+/-0.5 U/mg; K(m) for ATP is 0.69+/-0.07 mM and K(m) for (R,S) mevalonate diphosphate is 28.9+/-3.3 microM. Conserved polar residues predicted to be in the hMDD active site were mutated to test functional importance. R161Q exhibits a approximately 1000-fold diminution in specific activity, while binding the fluorescent substrate analog, TNP-ATP, comparably to wild-type enzyme. Diphosphoglycolyl proline (K(i)=2.3+/-0.3 uM) and 6-fluoromevalonate 5-diphosphate (K(i)=62+/-5 nM) are competitive inhibitors with respect to mevalonate diphosphate. N17A exhibits a V(max)=0.25+/-0.0 2U/mg and a 15-fold inflation in K(m) for mevalonate diphosphate. N17A's K(i) values for diphosphoglycolyl proline and fluoromevalonate diphosphate are inflated (>70-fold and 40-fold, respectively) in comparison with wild-type enzyme. hMDD structure indicates the proximity (2.8A) between R161 and N17, which are located in an interior pocket of the active site cleft. The data suggest the functional importance of R161 and N17 in the binding and orientation of mevalonate diphosphate.

[1]  H. Miziorko,et al.  Identification of active site residues in mevalonate diphosphate decarboxylase: Implications for a family of phosphotransferases , 2004, Protein science : a publication of the Protein Society.

[2]  A Sali,et al.  Structural genomics of enzymes involved in sterol/isoprenoid biosynthesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Miziorko,et al.  Investigation of the functional contributions of invariant serine residues in yeast mevalonate diphosphate decarboxylase. , 2005, Biochemistry.

[4]  H. Miziorko,et al.  Identification of Catalytic Residues in Human Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[5]  H. Miziorko,et al.  The Structure of a Binary Complex between a Mammalian Mevalonate Kinase and ATP , 2002, The Journal of Biological Chemistry.

[6]  F. Karst,et al.  The Saccharomyces cerevisiae mevalonate diphosphate decarboxylase is essential for viability, and a single Leu-to-Pro mutation in a conserved sequence leads to thermosensitivity , 1997, Journal of bacteriology.

[7]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  L. Samaranayake,et al.  Characterization, heterologous expression and functional analysis of mevalonate diphosphate decarboxylase gene (MVD) of Candida albicans , 2002, Molecular Genetics and Genomics.

[9]  R. Abeles,et al.  Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues. , 1987, Biochemistry.

[10]  A. M. Jabalquinto,et al.  Mevalonate 5-pyrophosphate decarboxylase from chicken liver. , 1985, Methods in enzymology.

[11]  E. Cardemil,et al.  Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: relevance of arginine 70 for catalysis. , 2004, Biochimie.

[12]  A. de Waard,et al.  Mevalonic acid pyrophosphate and isopentenylpyrophosphate. , 1959, The Journal of biological chemistry.

[13]  S. Dhe-Paganon,et al.  Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state. , 1994, Biochemistry.

[14]  F. Piriou,et al.  Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate. , 1985, The Biochemical journal.

[15]  J. Westover,et al.  The Function of Arg-94 in the Oxidation and Decarboxylation of Glutaryl-CoA by Human Glutaryl-CoA Dehydrogenase* , 2001, The Journal of Biological Chemistry.

[16]  James R. Brown,et al.  Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci , 2000, Journal of bacteriology.

[17]  A. M. Jabalquinto,et al.  Substrate binding order in mevalonate 5-diphosphate decarboxylase from chicken liver. , 1989, Biochimica et biophysica acta.

[18]  Zhiping Weng,et al.  Protein-protein docking: overview and performance analysis. , 2008, Methods in molecular biology.

[19]  P. Lipsky,et al.  Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism. , 1995, Cancer research.

[20]  L. Tong,et al.  Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism. , 2003, Structure.

[21]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[22]  H. Miziorko,et al.  Investigation of Invariant Serine/Threonine Residues in Mevalonate Kinase , 2001, The Journal of Biological Chemistry.

[23]  T. Hiratsuka,et al.  Preparation and properties of 2'(or 3')-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate, an analog of adenosine triphosphate. , 1973, Biochimica et biophysica acta.

[24]  B. Peterlin,et al.  Synergistic Activation of Transcription by the Mutant and Wild-type Minimal Transcriptional Activation Domain of VP16 (*) , 1996, The Journal of Biological Chemistry.

[25]  N. Grishin,et al.  Structure and mechanism of homoserine kinase: prototype for the GHMP kinase superfamily. , 2000, Structure.

[26]  K. Gibson,et al.  Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. , 1997, Journal of lipid research.

[27]  H. Miziorko,et al.  Phosphomevalonate kinase: functional investigation of the recombinant human enzyme. , 2006, Biochemistry.

[28]  M. Toth,et al.  Molecular Cloning and Expression of the cDNAs Encoding Human and Yeast Mevalonate Pyrophosphate Decarboxylase (*) , 1996, The Journal of Biological Chemistry.

[29]  Ding Li,et al.  Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase. , 2007, Bioorganic & medicinal chemistry letters.

[30]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[31]  T. A. Hall,et al.  BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT , 1999 .

[32]  Y. Yamori,et al.  Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat. , 1992, The Journal of biological chemistry.

[33]  Terry K. Smith,et al.  Crystal structures of Trypanosoma brucei and Staphylococcus aureus mevalonate diphosphate decarboxylase inform on the determinants of specificity and reactivity. , 2007, Journal of molecular biology.

[34]  T. Maung.  on in C , 2010 .

[35]  S. M. Sullivan,et al.  Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acid. , 2007, Biochemistry.

[36]  R. Bohacek,et al.  INHIBITION OF MEVALONATE 5-PYROPHOSPHATE DECARBOXYLASE BY A PROLINE-CONTAINING TRANSITION STATE ANALOG , 1996 .